Ipamorelin adjustments are based on symptoms and lab markers: If sleep and recovery improve at 200 mcg, you may stay at that dose If you want more pronounced GH effects, your physician may increase to 250 to 300 mcg A second daily dose (morning, fasted) can be added for enhanced GH support If water retention or joint stiffness develops, the dose may be reduced Key lab work at the 6 to 8 week mark: IGF-1 (confirms Ipamorelin is producing a GH response) thorough metabolic panel HbA1c and fasting glucose Lipid panel Lab work and monitoring Phase 4: Sustained Progress (Weeks 12 through 24) By this stage, both peptides are dialed in and working together effectively
In patients with obesity, there is no evidence for metabolic benefits of GH therapy in the absence of true GHD (153)
Johnson, G
At minus eighty degrees, researchers have documented minimal degradation even after ten years of storage
Early signs that peptides are working may include better sleep, increased energy, improved recovery after exercise, reduced cravings, less inflammation, or enhanced focus